Lu Zhang

机构：Weifang Medical University, University of Electronic Science and Technology of China, Chinese University of Hong Kong, Peking University, Wuhan University, Second Hospital of Shandong University, Renmin Hospital of Wuhan University, Henan Cancer Hospital, First Affiliated Hospital of Bengbu Medical College, Chengdu University of Traditional Chinese Medicine, University of Hong Kong · ORCID：0000-0003-3688-7013

发表论文 91 篇 · 总被引 1388 次 · h-index 21

代表论文

• Artificial intelligence in clinical decision support systems for oncology (2022 · International Journal of Medical Sciences · 被引 110)
• EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study (2023 · Radiotherapy and Oncology · 被引 64)
• Polyphenolic natural products as photosensitizers for antimicrobial photodynamic therapy: recent advances and future prospects (2023 · Frontiers in Immunology · 被引 55)
• KCNJ2/HIF1α positive-feedback loop promotes the metastasis of osteosarcoma (2023 · Cell Communication and Signaling · 被引 12)
• Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database (2023 · Frontiers in Oncology · 被引 11)
• Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021 (2025 · Frontiers in Endocrinology · 被引 8)